Annual consolidated financial statements 2022
PDF | 1.02 MB
Here, shareholders, analysts, the media and other interested parties can find all the key financial figures that allow a comprehensive assessment of the Hirslanden Group.
Investor Relations
Hirslanden is the Swiss division of Mediclinic International plc, an international private healthcare services group with a primary listing on the London Stock Exchange («LSE»), and secondary listings on the JSE and Namibian Stock Exchange. It has divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates, as well as a 29.9% shareholding in Spire Healthcare Group, a leading UK private hospital group also listed on the LSE.
Business Development (M&A)
The Group continues to evaluate opportunities to expand across the continuum of care as part of its growth strategy and focus on delivering quality value-based clinical care to clients in a co-ordinated manner. Should you wish to contact Hirslanden with specific investment proposals, please send us an e-mail.
Downloads
-
-
Annual consolidated financial statements 2021
PDF | 3.55 MB
-
Annual consolidated financial statements 2020
PDF | 5.69 MB
-
Annual consolidated financial statements 2019
PDF | 3.55 MB
-
Annual consolidated financial statements 2018
PDF | 2.48 MB
-
Annual consolidated financial statements 2017
PDF | 1.62 MB
-
Annual and Audit report 2015/16 - Hirslanden Private Hospital Group
PDF | 4.70 MB
-
Annual and Audit report FS 2014/15 - Hirslanden Private Hospital Group
PDF | 4.03 MB
Head of Investor Relations
James Arnold
Head of Mergers & Acquisitions
Franca Zanoni
Hirslanden AG
Corporate Office
Boulevard Lilienthal 2
CH-8152 Glattpark
Corporate Office
Boulevard Lilienthal 2
CH-8152 Glattpark